Juan Lantero-Rodriguez

Apr 27, 2023 | nature.com | Laia Montoliu-Gaya |Cecile Tissot |Agathe Vrillon |Wagner S. Brum |Juan Lantero-Rodriguez |Johanna Nilsson | +5 more

AbstractBlood phosphorylated tau (p-tau) biomarkers, at differing sites, demonstrate high accuracy to detect Alzheimerʼs disease (AD). However, knowledge on the optimal marker for disease identification across the AD continuum and the link to pathology is limited. This is partly due to heterogeneity in analytical methods.